Paul M. Carvey

8.9k total citations · 1 hit paper
115 papers, 7.1k citations indexed

About

Paul M. Carvey is a scholar working on Cellular and Molecular Neuroscience, Neurology and Neurology. According to data from OpenAlex, Paul M. Carvey has authored 115 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cellular and Molecular Neuroscience, 48 papers in Neurology and 26 papers in Neurology. Recurrent topics in Paul M. Carvey's work include Parkinson's Disease Mechanisms and Treatments (38 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Neurological disorders and treatments (22 papers). Paul M. Carvey is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (38 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Neurological disorders and treatments (22 papers). Paul M. Carvey collaborates with scholars based in United States, Taiwan and Germany. Paul M. Carvey's co-authors include Zao Dung Ling, Zaodung Ling, Jack W. Lipton, Bill Hendey, Chong Wai Tong, Yuangui Zhu, E. de Potter, Christopher G. Goetz, Harold L. Klawans and Mary B. Newman and has published in prestigious journals such as Science, Journal of Biological Chemistry and Neurology.

In The Last Decade

Paul M. Carvey

114 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

2000 1.0k citations Paul M. Carvey, Zaodung Ling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul M. Carvey United States	42	3.0k	2.5k	2.2k	1.8k	868	115	7.1k
Paul A. Lapchak United States	53	4.0k 1.3×	1.3k 0.5×	2.9k 1.3×	1.4k 0.8×	822 0.9×	167	8.8k
Ichiro Akiguchi Japan	50	3.1k 1.0×	2.4k 0.9×	3.2k 1.5×	2.4k 1.3×	2.0k 2.3×	277	9.2k
Fabrizio Gardoni Italy	53	4.7k 1.6×	1.6k 0.6×	3.0k 1.4×	1.8k 1.0×	2.0k 2.3×	150	8.6k
Ikuo Tooyama Japan	48	2.2k 0.7×	1.4k 0.6×	2.9k 1.3×	1.8k 1.0×	2.2k 2.6×	300	8.0k
José L. Venero Spain	43	1.8k 0.6×	1.4k 0.5×	2.4k 1.1×	2.5k 1.4×	1.1k 1.2×	131	6.7k
Barbara Monti Italy	32	2.1k 0.7×	989 0.4×	2.9k 1.3×	2.9k 1.6×	1.5k 1.7×	95	8.4k
Wayne A. Cass United States	39	3.5k 1.2×	1.6k 0.6×	1.7k 0.8×	811 0.5×	464 0.5×	82	5.5k
Rita Raisman‐Vozari France	42	3.0k 1.0×	2.2k 0.9×	1.6k 0.7×	993 0.6×	1.1k 1.2×	141	6.2k
José L. Labandeira‐García Spain	53	3.3k 1.1×	2.2k 0.9×	2.6k 1.2×	1.4k 0.8×	912 1.1×	200	7.4k
Hiroshi Katsuki Japan	48	2.4k 0.8×	1.1k 0.5×	3.0k 1.4×	1.3k 0.7×	1.1k 1.2×	248	7.9k

Countries citing papers authored by Paul M. Carvey

Since Specialization

Citations

This map shows the geographic impact of Paul M. Carvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Carvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Carvey more than expected).

Fields of papers citing papers by Paul M. Carvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Carvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Carvey. The network helps show where Paul M. Carvey may publish in the future.

Co-authorship network of co-authors of Paul M. Carvey

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Carvey. A scholar is included among the top collaborators of Paul M. Carvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Carvey. Paul M. Carvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Napier, T. Celeste, et al.. (2014). Dopamine Receptors and the Persistent Neurovascular Dysregulation Induced by Methamphetamine Self-Administration in Rats. Journal of Pharmacology and Experimental Therapeutics. 351(2). 432–439. 11 indexed citations

Toia, Giuseppe V., et al.. (2011). An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Experimental Neurology. 231(1). 160–170. 14 indexed citations

Carvey, Paul M., et al.. (2009). The blood–brain barrier in neurodegenerative disease: a rhetorical perspective. Journal of Neurochemistry. 111(2). 291–314. 183 indexed citations

Zhu, Yuangui, Paul M. Carvey, & Zaodung Ling. (2006). Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Research. 1090(1). 35–44. 228 indexed citations

Collier, Timothy J., Zao Dung Ling, Paul M. Carvey, et al.. (2004). Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Experimental Neurology. 191. S60–S67. 68 indexed citations

Gayle, Dave, et al.. (2002). Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide. Developmental Brain Research. 133(1). 27–35. 168 indexed citations

Carvey, Paul M., Zao Dung Ling, Caryl E. Sortwell, et al.. (2001). A Clonal Line of Mesencephalic Progenitor Cells Converted to Dopamine Neurons by Hematopoietic Cytokines: A Source of Cells for Transplantation in Parkinson's Disease. Experimental Neurology. 171(1). 98–108. 115 indexed citations

Kompoliti, Katie, Christopher G. Goetz, Toan Quang Vu, et al.. (2001). Estrogen Supplementation in the Posthypoxic Myoclonus Rat Model. Clinical Neuropharmacology. 24(1). 58–61. 2 indexed citations

Chen, Su & Paul M. Carvey. (2001). Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma. Rapid Communications in Mass Spectrometry. 15(2). 159–163. 25 indexed citations

10.

Storch, Alexander, Gesine Paul, Marie Csete, et al.. (2001). Long-Term Proliferation and Dopaminergic Differentiation of Human Mesencephalic Neural Precursor Cells. Experimental Neurology. 170(2). 317–325. 226 indexed citations

11.

Potter, E. de, Zao Dung Ling, & Paul M. Carvey. (1999). Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell and Tissue Research. 296(2). 235–246. 115 indexed citations

12.

Lipton, Jack W., et al.. (1998). The Magnitude of Brain Dopamine Depletion from Prenatal Cocaine Exposure Is a Function of Uterine Position. Neurotoxicology and Teratology. 20(4). 373–382. 28 indexed citations

13.

Carvey, Paul M., S. Pieri, & Zao Dung Ling. (1997). Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. Journal of Neural Transmission. 104(2-3). 209–228. 82 indexed citations

14.

Ling, Zaodung, S. Pieri, & Paul M. Carvey. (1996). Comparison of the Neurotoxicity of Dihydroxyphenylalanine Stereoisomers in Cultured Dopamine Neurons. Clinical Neuropharmacology. 19(4). 360–365. 26 indexed citations

15.

Carvey, Paul M., et al.. (1996). Loss of Striatal DA Innervation Increases Striatal Trophic Activity Directed at DA Neurons in Culture. Experimental Neurology. 140(2). 184–197. 30 indexed citations

16.

Carvey, Paul M., et al.. (1993). Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacology Biochemistry and Behavior. 46(1). 195–204. 12 indexed citations

17.

Carvey, Paul M., et al.. (1991). Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Experimental Neurology. 114(1). 28–34. 20 indexed citations

18.

Carvey, Paul M., et al.. (1990). Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacology Biochemistry and Behavior. 35(2). 291–300. 22 indexed citations

19.

Carvey, Paul M., et al.. (1989). LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 13(1-2). 199–210. 2 indexed citations

20.

Carvey, Paul M., et al.. (1986). L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.. PubMed. 43. 509–17. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact